How heart muscle cells mature after birth

Gene Regulatory Networks in Postnatal Cardiomyocyte Maturation

NIH-funded research University of Nebraska Medical Center · NIH-11362109

This project studies how gene regulation and chromatin changes help heart muscle cells mature after birth to improve treatments for heart disease and cell-based heart repair.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center NIH-funded
Lab location1 site (Omaha, United States)
Project IDNIH-11362109 on NIH RePORTER

What this research studies

From a patient perspective, researchers are focused on the switch that heart muscle cells make after birth so they can beat strongly for life. The team will study a key chromatin enzyme called CHD4 and the NuRD complex by manipulating them in heart cells and in postnatal mouse hearts to see how gene programs change. They will also use human pluripotent stem cell–derived cardiomyocytes to compare fetal-like and adult-like features, looking at gene activity, chromatin state, cell cycle exit, contractile structure, and metabolism. The work combines molecular assays, genomics, and stem-cell models to link gene regulation with the maturation steps that failing hearts or lab-grown cells struggle to complete.

Who could benefit from this research

Good fit: People with congenital heart disease linked to CHD4 or related genetic causes, or individuals willing to donate tissue, blood, or clinical data for research, would be most relevant to this project.

Not a fit: People without heart disease or those seeking an immediate treatment or clinical therapy are unlikely to receive direct benefit from this basic and preclinical research.

Why it matters

Potential benefit: If successful, this work could point to targets or methods to make lab-grown heart cells more adult-like and identify therapies to prevent or treat heart failure tied to immature cardiomyocytes.

How similar studies have performed: Previous laboratory studies have shown CHD4 is important for embryonic heart formation, but applying chromatin-focused approaches to promote postnatal cardiomyocyte maturation and improve stem-cell therapies is largely novel.

Where this research is happening

Omaha, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cardiac DiseasesCardiac Disorders
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.